Comparing conVEntional RadioTherapy with stereotactIC body radiotherapy in patients with spinAL metastases: study protocol for an randomized controlled trial following the cohort multiple randomized controlled trial design

Abstract

BackgroundStandard radiotherapy is the treatment of first choice in patients with symptomatic spinal metastases, but is only moderately effective. Stereotactic body radiation therapy is increasingly used to treat spinal metastases, without randomized evidence of superiority over standard radiotherapy. The VERTICAL study aims to quantify the effect of stereotactic radiation therapy in patients with metastatic spinal disease.Methods/designThis study follows the ‘cohort multiple Randomized Controlled Trial’ design. The VERTICAL study is conducted within the PRESENT cohort. In PRESENT, all patients with bone metastases referred for radiation therapy are enrolled. For each patient, clinical and patient-reported outcomes are captured at baseline and at regular intervals during follow-up. In addition, patients give informed consent to be offered experimental interventions. Within PRESENT, 110 patients are identified as a sub cohort of eligible patients (i.e. patients with unirradiated painful, mechanically stable spinal metastases who are able to undergo stereotactic radiation therapy). After a protocol amendment, also patients with non-spinal bony metastases are eligible. From the sub cohort, a random selection of patients is offered stereotactic radiation therapy (n = 55), which patients may accept or refuse. Only patients accepting stereotactic radiation therapy sign informed consent for the VERTICAL trial. Non-selected patients (n = 55) receive standard radiotherapy, and are not aware of them serving as controls. Primary endpoint is pain response after three months. Data will be analyzed by intention to treat, complemented by instrumental variable analysis in case of substantial refusal of the stereotactic radiation therapy in the intervention arm.DiscussionThis study is designed to quantify the treatment response after (stereotactic) radiation therapy in patients with symptomatic spinal metastases. This is the first randomized study in palliative care following the cohort multiple Randomized Controlled Trial design. This design addresses common difficulties associated with classic pragmatic randomized controlled trials, such as disappointment bias in patients allocated to the control arm, slow recruitment, and poor generalizability.Trial registrationThe Netherlands Trials Register number NL49316.041.14. ClinicalTrials.gov registration number NCT02364115. Date of trial registration February 1, 2015.

Single-fraction Stereotactic Body Radiation Therapy versus Conventionally Fractionated Radiation Therapy for the Treatment of Prostate Cancer Bone Metastases

“…Prior uncontrolled studies using single-fraction SBRT for palliation of osseous metastases with doses of 15 to 24 Gy report high rates of in-field and symptomatic relief. 19 , 20 , 21 , 22 Our prior institutional report of patients with PCa with bone-only metastases demonstrated that ≥18 Gy in a single fraction resulted in superior metastasis control, with a potential increased benefit for lesions treated to >18 Gy (vs 18 Gy). 7 A multi-institutional analysis of oligometastatic, treatment-naïve PCa treated with SBRT demonstrated improved local control in patients treated with a BED of >100 Gy.…”

Multidisciplinary treatment of pain caused by bone metastases in cancer patients: two case reports

“…Effective systemic palliative treatment decreases the intensity of symptoms related to malignancies. The most effective of these is palliative radiotherapy, which brings about a very satisfactory local analgesic effect in 85% of patients, and a complete resolution of pain symptoms in about 15-60% of patients [7]. The analgesic effect, brought about as a result of the destruction of radiation-sensitive macrophages and osteoclasts, is independent of the histopathological type of cancer [8].…”

Factors associated with patient-reported likelihood of using online self-care interventions: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study

“…Outcomes for the two groups are compared post-trial using the cohort’s routine data collection procedures. In most examples of cmRCTs, prior to enrolment in the cohort, patients are informed and consent to the possibility that they may be participants in trials but would not be notified about the trial if they are assigned to usual care 17–22…”